Fatal Haemoptysis Associated with Dramatic Response to Crizotinib in an ALK-Rearranged Lung Adenocarcinoma
The presence of an ALK (Anaplastic Lymphoma Kinase) rearrangement is a rare molecular feature in Non-Small Cell Lung Carcinoma (NSCLC), and concerns mainly non- or light smokers, young patients, with adenocarcinoma histological type. These tumours are particularly sensitive to Alk-targeted therapi...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
JCDR Research and Publications Private Limited
2016-03-01
|
| سلاسل: | Journal of Clinical and Diagnostic Research |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://jcdr.net/articles/PDF/7428/17805_CE(RA1)_F(T)_PF1(Vi_Om)_PFA(AK)_PF2(PP).pdf |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|